SCHEMBL3235671

SCHEMBL3235671

NC(=O)CCCCCC(=O)N(c1nc(-c2ccncc2)cs1)c1ccc(F)cc1N

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GRM1 Q13255 5/20 0.44
▸ MAPK14 Q16539 1/20 0.42
▸ ROCK1 Q13464 8/20 0.40
▸ CLK1 P49759 1/20 0.40
▸ PRKACA P17612 2/20 0.39
▸ ROCK2 O75116 4/20 0.38
▸ HDAC1 Q13547 3/20 0.38
▸ HDAC6 Q9UBN7 2/20 0.38
▸ HDAC9 Q9UKV0 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ HDAC2 Q92769 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3240737 0.94 MAPK14 (0.48) GRM1MAPK14HDAC1HDAC6HDAC9
SCHEMBL3262923 0.86 GRM1 (0.44) GRM1MAPK14ROCK1PRKACAROCK2
SCHEMBL3262051 0.84 CYP1A2 (0.43) MAPK14MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL3233610 0.84 KDM4E (0.38) MAPK14HDAC1MAPTNPC1RAB9A
SCHEMBL3238619 0.83 KDM4E (0.34) MAPK14HDAC1HDAC6HDAC9HDAC2
SCHEMBL3227664 0.82 HDAC1 (0.32) MAPK14HDAC1
SCHEMBL3233744 0.81 KMT2A (0.47) MAPK14HDAC1HDAC6HDAC9MAPT
SCHEMBL3230365 0.80 HDAC1 (0.43) HDAC1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL3241080 0.79 MPO (0.40) HDAC1MAPT
SCHEMBL3234299 0.78 RAB9A (0.48) HDAC1HDAC6HDAC9MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028193-A1 COMPOUNDS INCLUDING PIMELIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2010-03-11 — — WO disclosed
Send feedback